Contact
searchSearch
HMP Global
Login
Guidelines Quiz

Medication Monitoring in Patients With BPD

Edited by 
Brionna Mendoza
01/20/2026

Reference: American Psychiatric Association. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Borderline Personality Disorder, Second Edition. American Psychiatric Association Publishing; 2024.

Related Content

Mark Zimmerman, MD
Conference Coverage
Are We Overlooking Anger in Psychiatric Practice?
09/20/2025
Mark Zimmerman, MD
Mark Zimmerman, MD, shares some of the takeaways from his session presented at the 2025 Psych Congress titled "'I’m So Angry There Are No Talks About Anger': Recognizing and Managing Anger (the Overlooked Affect) in Clinical Practice."
Mark Zimmerman, MD, shares some of the takeaways from his session presented at the 2025 Psych Congress titled "'I’m So Angry There Are No Talks About Anger': Recognizing and Managing Anger (the Overlooked Affect) in Clinical Practice."
Mark Zimmerman, MD, shares some...
09/20/2025
Psych Congress Network
an illustrated laptop screen displaying a quiz
Quiz
Clinical Review Before Medication Initiation For BPD
07/28/2025
Maria Mantas
Do you remember the APA guideline recommendations?
Do you remember the APA guideline recommendations?
Do you remember the APA...
07/28/2025
Psych Congress Network
Differentiating Between BPD and Bipolar Disorder in Clinical Practice Transcript
05/14/2024
Saundra Jain, PsyD: Welcome back, everyone. Hey, Dr Chepke, Dr Jain. It's great to be here with both of you this afternoon. Thanks for joining us. We have a ton of questions. So I say, let's jump in. Craig, I'm gonna start with you if you...
Saundra Jain, PsyD: Welcome back, everyone. Hey, Dr Chepke, Dr Jain. It's great to be here with both of you this afternoon. Thanks for joining us. We have a ton of questions. So I say, let's jump in. Craig, I'm gonna start with you if you...
Saundra Jain, PsyD: Welcome...
05/14/2024
Psych Congress Network
Drs Chepke and Jain
Podcasts
Differentiating Between BPD and Bipolar Disorder in Clinical Practice
05/14/2024

With Rakesh Jain, MD, and Craig Chepke, MD

With Rakesh Jain, MD, and Craig Chepk...
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig Chepke, MD, continue their Psych Congress Regionals discussion and examine how to tease apart symptoms of borderline personality disorder from symptoms of bipolar disorder, and how to get to the right diagnosis.
Rakesh Jain, MD, and Craig...
05/14/2024
Psych Congress Network

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, MSN, APRN, PMHNP-BC
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use